Killing activity of human umbilical cord blood-derived TCRValpha24+ NKT cells against normal and malignant hematological cells in vitro: a comparative study with NK cells or OKT3 activated T lymphocytes or with adult peripheral blood NKT cells Masao HagiharaBalgansuren GansuvdTomomitsu Hotta Original Article Pages: 1 - 8
Vaccination of Stage IV patients with allogeneic IL-4- or IL-2-gene-transduced melanoma cells generates functional antibodies against vaccinating and autologous melanoma cells Michele MaioEster FonsattiGiorgio Parmiani Original Article Pages: 9 - 14
Binding to CD20 by Anti-B1 Antibody or F(ab')2 is sufficient for induction of apoptosis in B-cell lines Pina M. CardarelliMaire QuinnGeoffrey Yarranton Original Article Pages: 15 - 24
Generation of activated and antigen-specific T cells with cytotoxic activity after co-culture with dendritic cells Angela MärtenTim GretenIngo G. Schmidt-Wolf Original Article Pages: 25 - 32
A mutated superantigen SEA D227A fusion diabody specific to MUC1 and CD3 in targeted cancer immunotherapy for bile duct carcinoma Shin-ichi TakemuraToshio KudoIzumi Kumagai Original Article Pages: 33 - 44
Vaccination with autologous tumour antigen-pulsed dendritic cells in advanced gynaecological malignancies: clinical and immunological evaluation of a phase I trial Juan HernandoTjoung-Won ParkThomas Bauknecht Original Article Pages: 45 - 52
The presence of interleukin-2 receptor alpha in the serum of colorectal cancer patients is unlikely to result only from T cell up-regulation Andy HuangHelen QuinnTimothy G. Allen-Mersh Short Communication Pages: 53 - 57
Progress in vaccination against cancer (PIVAC) 2001, Robinson College, University of Cambridge, UK Robert C. ReesGraham PawelecAdrian Robins Symposium Series Pages: 58 - 61